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Abstract
The conventional auscultatory methods for measuring blood pressure have been used
to screen, diagnose, and manage hypertension since long. However, these have been
found to be prone to errors especially the white coat phenomena which cause falsely
high blood pressure readings. The Mercury sphygmomanometer and the Aneroid variety are no longer recommended by WHO for varying reasons. The Oscillometric devices
are now recommended with preference for the Automated Office Blood Pressure measurement device which was found to have readings nearest to the Awake Ambulatory
Blood Pressure readings. The downside for this device is the cost barrier. The alternative is to use the simple oscillometric device, which is much cheaper, with the rest and
isolation criteria of the SPRINT study. This too may be difficult due to space constraints
and the post-clinic blood measurement is a new concept worth further exploration.

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in
any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
© 2021 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC
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I NTRO D U C TI O N

reported to be more common in smokers, hypertensives on treatment, males, elderly, alcohol consumers, African Americans, diabet-

In 2015, the global prevalence of hypertension was estimated to be

ics, and chronic kidney disease. In the study by Siddiqui et al, it was

more than 1.1 billion.1 The highest prevalence of raised blood pres-

found that patients with MUCH had evidence of heightened out-of-

sure (BP) among people aged ≥18 years was in low-income countries

clinic sympathetic activity compared with true controlled hyperten-

(28.4%) and middle-income countries (25.5%). In 2017, the Global

sive patients.15

Burden of Disease study found that raised systolic blood pressure

Problems with OBP measurements have led to the development

(SBP) was the leading modifiable risk factor for death globally, with

of various devices and methodologies that have proven to give more

10.4 million deaths annually attributed to this cause. 2

accurate BP measurements. This includes the HBPM device which

The diagnosis of hypertension has classically been made by

is used by the patient at home over a period of days or weeks and

office/clinic BP measurements. This has evolved over time from

the ABPM device which is usually applied for 24 h and is prepro-

Mercury sphygmomanometers to Aneroid, Hybrid (quasi-mercury)

grammed to take measurements at set intervals. The ABPM is now

and then Oscillometric devices.3,4 However, there have been mul-

regarded as the best technology for BP measurement3,4,16,17 fol-

tiple problems in obtaining correct BP readings in the office. These

lowed by HBPM16,18 as both these methods can diagnose masked

include observer errors caused by lack of concentration, poor hear-

hypertension and avoid the pitfall of white coat hypertension in ad-

ing, confusion of auditory, and visual cues, etc. The most important

dition to other benefits.

factor is failure to interpret the Korotkoff sounds accurately, espe-

This review is limited to the device types and methodologies

cially for diastolic blood pressure (DBP). Terminal digit preference

used for BP measurement in the office/clinic only and will not discuss

and observer bias are also causes of inaccurate measurements.5

HBPM or ABPM. The methodologies employed during measurement

Device problems are also common. In a study of 210 mercury

including the device types, individual measuring or unattended mea-

and aneroid sphygmomanometer, nearly half had some fault.6

surements, prior rest period, and timing of measurements will be dis-

Methodology errors, which are mostly due to inadequate attention

cussed. The standardized BP measurement techniques as mentioned

to the recommended guidelines, are a major cause of inaccuracy

in the various hypertension guidelines must be followed regardless

of BP measurement. BP is rarely measured in accordance with the

of the methodology employed.3,4,7,16,19 It is also clarified that the

strict guidelines in a screening or clinical setting, and the accuracy of

words office and clinic are used interchangeably in this review.

7

measurement is often disregarded or ignored. In a study of 150 patients, BP measured by usual care was compared with that measured
strictly following the American Heart Association guidelines. There
was a mean lowering of about 12/6 mmHg when the guidelines were
followed.8
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2.1 | Auscultatory devices

Another major problem with office blood pressure (OBP) measurements is the alerting response which causes the white coat

The first group are the auscultatory devices where a trained ob-

phenomena seen as white coat hypertension in non-hypertensives

server uses a stethoscope to listen to the Korotkoff sounds and

and white coat effect in known hypertensives.

3,4,7,9

The pressor and

makes a determination as to the SBP and DBP. Thus, these are all

tachycardiac responses to the alerting reaction that accompanies

prone to the observer errors mentioned above and also to the white

sphygmomanometric blood pressure measurement is characterized

coat phenomenon as unattended readings are not possible.

by a behavior of the adrenergic nervous system that causes muscle sympathoinhibition and skin sympathoexcitation.10 In a study
by Dolan et al, the overall prevalence of white coat hypertension

2.1.1 | Mercury sphygmomanometer

was 15.4% and a higher prevalence was seen among older adults,
females, and non-smokers.11 This is seen more often when doc12,13

tors measure the BP and less so with nurses.

This has been the classical way of measurement and has been

It is not due to

regarded as the gold standard. The validity of newer devices is

device error as the oscillometric home blood pressure measurement

checked against this device. It is inexpensive, requires limited

(HBPM) gives lower BP readings at home but the same device when

maintenance, and requires no energy source. It is still being used

used in a clinical setting in the Spanish ABPM registry gave markedly

by a large number of doctors worldwide. In a study of 774 fam-

14

higher BP readings.

ily physicians in Canada published in 2017, 54.2% were still using

The inability to diagnose masked hypertension is another draw-

the auscultatory methods (which include both mercury and aner-

back of OBP as by definition, masked hypertension in untreated hy-

oid sphygmomanometers) for screening, 21.4% for diagnosis, and

pertensive patients or masked uncontrolled hypertension (MUCH)

63.6% for follow-up of hypertension. 20 A study of 445 primary

in treated hypertensive patients is controlled BP in clinic as mea-

care doctors in Hong Kong published this year revealed that the

sured by OBP but uncontrolled BP out-of-clinic as measured by 24-h

auscultatory methods were being used by 63.1% for screening,

ambulatory BP monitoring (ABPM) or by HBPM.15 The prevalence

56.4% for diagnosis, and 72.4% for follow-up. 21 In an unpublished

4

in the population is reported as 10%–26% (mean 13%). This is

study done in Pakistan by Bilal M. and Siddique S., in 500 doctors

|
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(over 2/3rds of these working as junior hospital doctors in the field

vast majority being oscillometric. Only 4 recommended devices have

of cardiology), 61% were using mercury sphygmomanometer and

auscultatory component. It is therefore a validated methodology

24% the aneroid variety (personal communication). The problems

and as many countries/regions have separate accreditation lists for

with this instrument are the use of a toxic material, that is, mercury,

BP devices, it is possible that in certain countries, it may be more

which is being phased out following the Minamata Convention. 22

prevalent.

It is no longer recommended by the World Health Organization
(WHO) due to the toxic material and should be phased out (WHO
Technical Specifications for Automated non-invasive BP measur-

2.2 | Oscillometric devices

ing devices with cuff, p. 6). 23
These are of two types:
The simple type designed for home blood pressure monitoring

2.1.2 | Aneroid sphygmomanometer

which is also being used in many office practices. The one with the
upper arm cuff is recommended and not the wrist or finger varieties

This device has the advantage of being easy to carry around and

as the latter have not been clinically validated. 23 This device has to

use, is inexpensive, and needs no energy source. However, it is

be activated by an individual, either a professional, that is, doctor

prone to inaccuracy in case of mishandling, for example, physical

or nurse etc or by the patient. There are reports of having white

shocks, and needs to be calibrated at fixed intervals (at least every

coat phenomena by this process.3,4,16 In 27 211 patients with hyper-

6 months). 23 Unlike the mercury device in which the mercury level

tension in the Spanish ABPM Registry, the mean oscillometric OBP

can be checked visually, there is no way for the individual performing

was 160/89 mmHg, compared with a mean awake ambulatory blood

the test to be sure of the accuracy of this device. This device is also

pressure (ABP) of 135/78 mmHg.14 Thus, simply replacing manual

no longer recommended by WHO because of the requirement for

BP with an oscillometric device did not eliminate the white coat ef-

frequent recalibration and observer training and retraining (WHO

fect if other parameters like rest, isolation, and unattended BP mea-

Technical Specifications for Automated non-invasive BP measuring

surement were not followed.

devices with cuff, p. 6). 23

The professional type, again with the upper arm cuff. This has
an inbuilt delay before starting the measurement and can be programmed to do repeated measurements (at least three) with a time

2.1.3 | Hybrid (quasi-mercury)

delay between measurements. This is called the automated office
blood pressure measurement (AOBP). 25 This is the method that

An electronically generated pressure column (quasi-mercury) sphyg-

was employed in the SPRINT study comprising 9316 patients in

momanometer is a sphygmomanometer using an electronic analog

which the SBP by AOBP was found to be similar to SBP of 24 h

column instead of a mercury column.3,4,7 With a hybrid sphygmoma-

ABP and about 7 mm less than daytime ambulatory SBP. 26 In a

nometer, a liquid crystal display column or light-emitting diode screen

meta-analysis to examine the association between AOBP and

moves smoothly like a mercury column or aneroid-like display. It is an

OBP readings (manual or oscillometric) measured in routine clin-

auscultatory method and is, therefore, prone to the observer errors

ical practice and in research studies, and awake ABP, it was found

common to this method including the white coat phenomenon.

that in samples with systolic AOBP of 130 mmHg or more, routine
office and research SBP readings were substantially higher than
AOBP readings, with a pooled mean difference of 14.5 mmHg

2.1.4 | Automated auscultatory

(95% CI, 11.8–17.2 mmHg; n = 9; I2 = 94.3%; p < .001) for rou-

This is an electronic BP measuring device which uses high sensitiv-

n = 9; I2 = 85.7%; p < .001) for research SBP readings. There was

ity microphones to detect the Korotokoff sounds. Thus, the human

no significant difference in SBP readings between awake ABP and

ear is not required and measurements can be fully automated which

AOBP, with a pooled mean difference of 0.3 mmHg (95% CI, −1.1

eliminates the white coat effect seen with other auscultatory de-

to 1.7 mmHg; n = 19; I2 = 90%; p < .001). 25 The authors concluded

vices. However, the area of automated BP measurement has been

that AOBP should now be the preferred method for recording BP

virtually taken over by the automated oscillometric technique (dis-

in routine clinical practice.

tine office SBP readings and 7.0 mmHg (95% CI, 4.9–9.1 mmHg;

cussed below) and this device is not specifically mentioned in any of

There are question marks over the prognostic significance of

the major hypertension guidelines.3,4,7,16,19 However, some of these

the AOBP measurements.3 However, in a study by Campbell et al in

do mention validated devices. The dable Educational Trust web site

176 patients, the AOBP readings correlated better with carotid in-

makes up-to-date evidence-based information available regarding

tima-media thickness than the auscultatory BP. 27 Another study

BP devices and lists the BP devices validated under international

by Andreadis et al concluded that high-quality AOBP readings and

protocols. 24 Under its latest listing of recommended Automated

ABP measurements correlate equally well with left ventricular mass

Devices for Clinical Use, there are over a 100 different devices, the

indices. 28
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2.3 | New innovations

the mean of 3 automated measurements performed in a separate
room after 5 min of rest.

There are many new innovations in the market which are cuff-less

Unattended and attended AOBP were 134.2/80.6 and

and calculate the BP from various other parameters including Pulse

135.7/80.6 mmHg. Their conclusion was that unattended and at-

transit time, Ultrasound or Magnetic method, Tissue characteris-

tended office BP measurements achieve comparable results, if mea-

tic methods, Machine-learning methods, Heart-rate variation and

surements take place at a familiar general practitioner’s office. In

heart-rate power spectrum ratio, Photoplethysmography, Heart

an editorial by Stergio et al, six studies are mentioned which con-

rate, and smartphone technology. None of these technologies have

sistently showed that when several OBP measurements are taken

been validated, they are not regulated, and there is no unified, stand-

using automated devices without talking to the patient, the presence

ard system to evaluate their accuracy, performance, or use. Thus,

of the observer has little or no effect on measured OBP (95% CIs in

these emerging technologies cannot yet be recommended for clini-

all studies excluded any clinically important difference).33 Moreover,

cal use (WHO Technical Specifications for Automated non-invasive

in a study by Salvetti et al, it was shown that both left ventricular

BP measuring devices with cuff, pp.30–31). 23

mass index and carotid intima-media thickness were similarly correlated with attended and unattended systolic BP.34

3
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Another advantage of AOBP shown in trials is that it is fairly con-

M E TH O D O LO G I E S

stant no matter where it is performed. In a study by Chambers et al, 35
AOBP measurements were obtained in family physicians’ offices and

3.1 | Individual performing the test

were compared with those obtained in community pharmacies in
275 patients aged 65 years or older. The mean difference between

3.1.1 | Doctors

the measurements at the two locations was <1.1/0.5 mmHg. Their
conclusion was that measurements of blood pressure using an au-

BP readings taken by doctors have been shown to be the most un-

tomated device in a pharmacy can provide accurate and valid blood

reliable as the worst form of white coat phenomena manifest when

pressure information that can be used in the diagnosis and manage-

doctors perform the measurement.12

ment of hypertension among older adults in the community. In another study by Armstrong et al,36 AOBP readings using the BpTRU
device recorded with the patient resting quietly in the waiting room

3.1.2 | Nurses

were obtained in patients referred for ABPM and the relationship
between the AOBP and awake ABP (mmHg) was examined. In 422

It has been uniformly seen in multiple trials that nurses’ BP read12

ings are less than the ones taken by doctors.

patients, the mean (±SD) awake ABP (139.4 ± 13.4/80.7 ± 10.6)

However, the white

was similar to the mean AOBP recorded in the waiting room

coat phenomenon is not totally nullified and is still seen in these

(140.5 ± 19.8/83.1 ± 11.2), with both values being significantly lower

readings.13

than a single office BP (155.1 ± 18.7/90.2 ± 12.7) taken by a nurse.
They concluded that AOBP readings recorded in a waiting room are
comparable with the awake ABP, making it possible to obtain AOBP

3.1.3 | Automated readings
These could be attended or unattended.
Fully automated unattended readings have been shown to be

in clinical practice without the need to occupy an examining room.

3.2 | Prior rest period and timing of BP readings

the lowest and most compatible with daytime ABPM readings. 29
However, in a study by Julia Holler et al, 30 in 42 consecutive pa-

3.2.1 | Prior rest period

tients with hypertension, attended AOBP was 131.7/83.4 mmHg
compared with unattended AOBP of 131.6/82.4 mmHg. This was

This has been recommended as part of the standardized technique

contrary to the results of a trial by Berkhof et al. 31 Their study

for all BP measurements.3,4,7,16,19 However, the quality of this rest

consisted of 120 patients who performed three self-initiated and

period has been redefined lately and is now taken as rest in an iso-

three fully automated BP measurements. In this cohort (mean age

lated room with no talking or interaction with anyone. 26

58.0 ± 14.1 years, mean OBP 153.6 ± 23.8/86.3 ± 14.0 mmHg,
44.1% female), self-initiated BP measurement resulted in a
2.1 ± 6.8/0.9 ± 4.0 mmHg higher systolic and diastolic blood

3.2.2 | Timing of BP measurements

pressure (DBP) compared with fully automated self-measurement
(p = .001/.018). Thus, there was a small but significant reduction

These can be pre-clinic, in-clinic, or post-clinic.

of both SBP and DBP when the fully automated device was used.

BP has often been take pre-clinic, usually by a nurse or trained

In another study by Bauer et al, 32 unattended to attended AOBP

assistant, and this is usually found to be less than the in-clinic BP

were compared in 51 patients. Unattended BP was calculated as

measured by the doctor.12,13

|
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The post-clinic BP is an interesting concept which has not been
extensively investigated. In a study from Aga Khan University
Hospital in Karachi, Pakistan,

37

5

prognostic value of post-clinic BP and its association with cardiovascular outcomes.38

the pre-clinic reading was taken

by the assessment nurse after the patients waited for 16 ± 1.7 min
before being seen. The in-clinic reading was taken by the physician

4
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inside the clinic room after 15 ± 2.1 min wait. After the clinic encounter was over, participants were asked to be seated, with a prohibition

It can be seen from the above that AOBP has the best correlation

of smoking or exertion but not of talking or interaction with others,

with daytime ABP readings. However, as with all other devices, it too

for another 15 min in the waiting area. An interval of 15 min was

has its share of problems.

chosen to match the time interval that the patients waited before
pre-clinic and in-clinic readings were taken. After 15 ± 1.3 min, participants were called back to another clinic room where post-clinic

4.1 | Cost and durability

readings were taken. The two post-clinic readings were taken by a
research officer at an interval of 1 min. A standard BP measurement

The upfront cost is 500–900 US dollars (as found on Internet search),

protocol was observed for all four BP readings. BP was measured

and there would be additional costs for training and regular mainte-

in the right arm at heart level, while participants were seated in a

nance. This is a fairly large figure compared with validated simpler

chair with a back-rest. They were asked not to talk during the time

oscillometric devices which are about 1/10th the price (this estima-

the readings were taken. All BP readings were taken using an au-

tion will vary in different countries depending on taxation, pricing

tomated and validated Omron HEM7221-E to avoid inter-observer

methodology, availability etc). To make provision for this device for

variability. Mean SBP taken pre-clinic, in-clinic, post-clinic 1, and

even 50% of the practicing doctors in a country would involve a con-

post-clinic 2 were 126 ± 20 mmHg, 131 ± 23 mmHg, 126 ± 20 mmHg

siderable outlay. Then, there is also the question of durability which

and 121 ± 21 mmHg, respectively (p < .001). Mean DBP taken pre-

is not clearly defined but these devices will have to be replaced at

clinic, in-clinic, post-clinic 1, and post-clinic 2 were 77 ± 12 mmHg,

variable intervals.

81 ± 13 mmHg, 79 ± 12 mmHg, and 79 ± 11 mmHg, respectively
(p < .001). The post-clinic 2 SBP and DBP were 10 mmHg and
2 mmHg lower than the in-clinic SBP and DBP, respectively.37

4.2 | Validation

The same group then repeated the study, this time comparing with ABP also.38 After the post-clinic BP reading was taken, a

This is an essential requirement mentioned in the above guide-

24 h ABPM monitor (SpaceLabs, model: 90217A) was attached to

lines and needs to be done according to the Universal Validation

each participant which took BP and pulse readings every half hour

Standards (WHO Technical Specifications for Automated non-inva-

during the daytime and every hour during nighttime. Among the

sive BP measuring devices with cuff, table 3). 23 This involves extra

three readings taken during a clinic visit, mean (±SD) SBP pre-clinic,

effort on the part of the manufacturers and regulators, and the users

in-clinic, and 15 min post-clinic were 153.2 ± 23, 152.3 ± 21, and

have to be aware of the validated lists of models.

140.0 ± 18 mmHg, respectively. Mean (±SD) DBP taken pre-clinic,
in-clinic, and 15 min post-clinic were 83.5 ± 12, 90.9 ± 12, and
86.4 ± 11 mmHg, respectively. Mean (±SD) daytime ambulatory

4.3 | Separate room

SBP, DBP, and pulse readings were 134.7 ± 15, 78.7 ± 15 mmHg,
and 72.6 ± 12/min, respectively. This study replicated the findings

This may not be a problem for the resource rich countries but is a

of their previous study and the post-clinic SBP correlated better

major obstacle in resource poor countries, both in a busy hospital

with the daytime systolic ABP reading than the pre-clinic or in-clinic

outpatient department and in family practices. However, at least one

readings. The authors stated that their results were comparable to

study has shown that AOBP readings in a patient resting quietly in a

Mancia et al’s study

39

which showed that patients’ BP and heart

rate increased when visited by a physician or a nurse, the rise being

waiting room (and not alone in a separate room) were comparable to
the awake ABP measurements.36

higher with the physician. Both heart rate and BP then declined,
over the next 10 min, by about 10/5 mmHg owing to the reduction
in the alert reaction. Another study showed that serial automated

4.4 | Accuracy and maintenance

office SBP readings taken in a quiet room using the ABPM device
decreased by about 12 mmHg to reach a plateau over 15 min and

The frequency of accuracy checks must be in accordance with man-

these readings remained similar at 30 min.40 They concluded that

ufacturer’s recommendations, which depends on the type of tech-

post-clinic BP can be more reliable than the conventional methods as

nology. The usual interval is once every 1 or 2 years. Nevertheless,

well as being more cost-effective upfront in comparison with ABPM

experience indicates that, if an oscillometric device is used fre-

for assessment of hypertension and adjusting medications but fur-

quently every day in clinical practice, the integrity of the cuff and

ther studies with a larger sample size are required to determine the

tubing and the adequacy of the power source should be checked at

>5 min

Caffeine, exercise, Smoking

Yes

Yes

Yes

Upper arm

Appropriate sized

2 mm/s

I

Rest period

Avoid

Empty urinary bladder

No talking

Bare arm

Cuff position

Cuff size

Deflation

Korotkoff SBP

All readings

1–2 min

-

First visit

-

-

Average of;

Interval between readings

Record heart rate

BP in both arms

Standing BP

Time for standing BP
measurement

At 1 and 3 min

All at first visit

First visit

Yes

1–2 min

All readings

3

V

I

-

Appropriate sized

Upper arm

-

-

-

-

>5 min

Sitting, back supported

Auscultatory or Oscillometric semi-automated,
Hybrid quasi-mercury, AOBP

ESC 2018

At 2 min

All at first visit

One visit

Yes

>1 min

Last 2 readings

3

V

I

2 mm/beat

Appropriate sized

Upper arm

Yes

Yes

-

-

>5 min

Sitting, back supported,
legs uncrossed

AOBP
Oscillometric
Aneroid
Mercury

CHEP 2020

-

Diabetics, elderly

First visit

Yes

1–2 min

All readings

≥2

V

I

2–3 mm/beat or second

Appropriate sized

Upper arm

-

Yes

-

Smoking, Caffeine, Alcohol

Few mins

Sitting, back supported,
legs uncrossed

Mercury
Aneroid
Electronic -quasi mercury

JSH 2019

-

Diabetics, elderly, if fall
suspected

First visit

Yes

1–2 min

All readings

2

V

I

2 mm/s

Appropriate sized

Upper arm

-

-

-

-

>5 min

Sitting

Oscillometric
Mercury
AOBP

Chinese HTN 2018

a

Korotkoff IV is recommended for specific conditions.

Abbreviations: AHA, American Heart Association4; CHEP, Canadian Hypertension Education Program Supplemental Table 116; Chinese HTN, Chinese Hypertension Guidelines19; ESC, European Society of
Cardiology3; JSH, Japanese Society of Hypertension.7

≥2

No. of readings

V

Sitting, back supported, feet
flat on the floor

Position

Korotkoff DBP

Mercury, Aneroid, Hybrid
quasi-mercury, AOBP

Device type

a

AHA 2017

Item

TA B L E 1 Comparison of BP measurement methodology in various guidelines
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least once a month by users or clinical engineers (WHO Technical

2–3 mm/beat or second. The recommended number of readings

Specifications for Automated non-invasive BP measuring devices

per visit varies from 2–3, with the Canadian guidelines the only

with cuff, p. 14). 23

one eliminating the first reading, and averaging is recommended
by all. The major difference is perhaps in the recommendations

4.5 | Arrhythmias

for standing BP, both for whom it is necessary and the timing of
its measurement.
The recommendations for devices in these guidelines are as

Standard AOBP device still has problems with accurate meas-

follows;

urement of BP in patients with arrhythmias, for example, atrial
fibrillation.41 In the case of arrhythmia, additional readings by
auscultation may be required to estimate the average systolic and

5.1 | ESC/ESH 2018 guidelines

diastolic pressure.16
“Auscultatory or oscillometric semiautomatic or automatic sphyg-

4.6 | Masked hypertension

momanometers are the preferred method for measuring BP in the
doctor’s office. These devices should be validated according to
standardized conditions and protocols.”

As masked hypertension patients by definition have normal OBP
measurements, lowering of the office BP by AOBP may increase

Presently, the relationship between BP readings ob-

the prevalence of such patients. In a sub-study of the CAMBO

tained with conventional office BP measurement and

trial,42 ABP, AOBP, and conventional manual office BP were

unattended office BP measurement remains unclear,

checked. The prevalence for masked hypertension based upon

but available evidence suggests that conventional of-

both SBP and DBP was similar being 11%–15% for AOBP and

fice SBP readings may be at least 5–15 mmHg higher

19%–20% for manual BP patients on single visits, but decreased to

than SBP levels obtained by unattended office BP

6% and 10% when readings from the first two visits were used and

measurements. There is also very limited evidence on

to 4% and 6% when all three visits were used for the AOBP and

the prognostic value of unattended office BP mea-

manual BP groups, respectively. The authors concluded that the

surements, i.e. whether they guarantee at least the

prevalence of masked hypertension is lower with AOBP compared

same ability to predict outcomes as conventional of-

with manual BP and the number of patients with masked hyper-

fice BP measurements.3

tension decreases if the criteria for having this condition need to
be met on multiple visits.

Thus, the ESC/ESH guidelines recommend both auscultatory and
oscillometric devices with the proviso that all devices should be vali-

4.7 | Clinical implications on patient-doctor
relationship
The use of AOBP may have some impact on developing this rela-

dated and but with no preference for one over the other. AOBP is mentioned but with lack of clarity about its prognostic value.

5.2 | ACC/AHA 2017 Guidelines

tionship. However, this rapport is built by the doctor being present
and measuring the BP himself/herself, often while carrying on a con-

The clinical standard of auscultatory measures cali-

versation with the patient. It has been seen that these are the very

brated to a column of mercury has given way to oscil-

actions which are the main reasons of white coat phenomenon and

lometric devices.

falsely high OBP.39
…only devices with validated measurement protocol
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can be recommended for use.
Although much of the available BP-related risk in-

Table 1 compares select international guidelines regarding OBP.

formation and antihypertensive treatment trial ex-

The recommendations are mostly similar with some being more

perience have been generated by using “traditional”

detailed than others. The differences are minor and mostly insig-

office methods of BP measurement, there is a grow-

nificant. The rest period in the Japanese guidelines is mentioned

ing evidence base supporting the use of automated

as a ‘few minutes’ which is rather non-specific while the others

office BP measurements.4

all define it as >5 min. The deflation rate is mentioned as 2 mm/s
in the American and Chinese guidelines and 2 mm/beat in the
Canadian guidelines while the Japanese guidelines recommends

The ACC/AHA guidelines thus prefer validated oscillometric devices with a bias toward AOBP.
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5.3 | Hypertension Canada’s 2020 guidelines

device may be better for the latter. Although most countries have
signed the Minamata declaration, some of the under developed ones

Use of standardized measurement techniques and in-

have not got it ratified from their respective parliaments and are

dependently validated equipment for all methods (au-

not implementing it. These countries continue to use the mercury

tomated OBPM (AOBP), OBPM, ABPM, and HBPM)

sphygmomanometer despite its multiple problems as stated above.

is recommended. Unless specified otherwise, mea-

In general, clinics and hospitals with adequate financial resources

surement using electronic (oscillometric) upper arm

and access to technical back up would be better served by AOBP

devices is preferred over auscultation.

while those lacking these can choose the simple oscillometric device.

AOBP is the preferred method of performing OBPM.16
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Thus, the Canadian Hypertension guidelines generally allow only
oscillometric devices with AOBP being the preferred method for

Conventional OBP methods of auscultatory mercury or aneroid

OBPM for both screening and management. It further specifies that

devices are both not recommended by WHO, the former due to

diagnosis should be based on ABPM or HBPM and not on OBPM.

mercury toxicity and the latter due to frequent need for recalibration. Also, both these methods need well trained personnel and are

5.4 | Japanese hypertension guidelines 2019

prone to white coat phenomena as these cannot be unattended.
Oscillometric devices are recommended with the unattended, fully
automated, AOBP giving the best results. However, due to the en-

Office blood pressure is measured by the ausculta-

hanced cost and area requirements it cannot be recommended as the

tion method, which is the standard procedure, but the

primary method in resource poor countries at present. Moreover,

use of an automatic sphygmomanometer of the upper

general usage of this device would impact the BP levels for both di-

arm type is also permitted.7

agnosis and treatment as there is a 5–15 mmHg reduction in SBP levels with AOBP compared with conventional methods as mentioned

The first choice for OBP, therefore, remains the auscultatory
method although it is mentioned that mercury sphygmomanometers
will be banned from January 1, 2021.

in the ESC guidelines above. This point would need another review.
The alternative would be the self-initiated oscillometric device,
duplicating the rest and isolation protocol used in SPRINT if possible. This too may be difficult due to area constraints in busy outpa-

5.5 | Chinese hypertension guidelines 2018

tient departments of hospitals and family practices. In which case,
the post-clinic method may be useful in obtaining a reading closer to
daytime ABP reading. However, this method needs more validation

Upper arm medical electronic sphygmomanometer,

with further studies in different population groups. Finally, it may

which has been validated by international standard-

be mentioned that with the rapid development in cuff-less technol-

ized protocols (ESH, BHS and AAMI), or mercury

ogies, all this may be obsolete in the not too distant future and we

sphygmomanometer, which is up to the metrological

may all be measuring our BP on mobile phones.

standard (will be deprecated gradually), are used for
the measurement. Automated office BP measure-

C O N FL I C T O F I N T E R E S T

ment (AOBP) can reduce the white coat effect, which
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